Published in Obesity and Diabetes Week, September 18th, 2006
"Myeloperoxidase (MPO) is an oxidant-generating enzyme present in macrophages at atherosclerotic lesions and implicated in coronary artery disease (CAD). Although mouse models are important for investigating the role of MPO in atherosclerosis, neither mouse MPO nor its oxidation products are detected in lesions in murine models," scientists writing in the Journal of Lipid Research report.
"To circumvent this problem," proposed L.W. Castellani and colleagues, Sidney Kimmel Cancer Center, "we generated transgenic mice expressing two...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.